Form 8-K - Current report:
SEC Accession No. 0001493152-25-002176
Filing Date
2025-01-14
Accepted
2025-01-14 16:45:22
Documents
14
Period of Report
2025-01-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46065
  Complete submission text file 0001493152-25-002176.txt   274052

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20250113.xsd EX-101.SCH 3883
3 XBRL DEFINITION FILE cdt-20250113_def.xml EX-101.DEF 30185
4 XBRL LABEL FILE cdt-20250113_lab.xml EX-101.LAB 37007
5 XBRL PRESENTATION FILE cdt-20250113_pre.xml EX-101.PRE 27208
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6154
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 25529865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)